Last updated: January 20, 2026
Sponsor: Hospices Civils de Lyon
Overall Status: Completed
Phase
N/A
Condition
Posterior Uveitis
Treatment
Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum.
Clinical Study ID
NCT05774496
69HCL22_1041
2022-A02496-37
Ages 21-50 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Being a woman
Born before March 2022
Suffering from congenital toxoplamosis
Exclusion
Exclusion Criteria:
Refusal to give informed consent
Any condition that would limit the ability of the patient to give consent
Psychiatric cares
To be deprived of liberty
To be under administrative supervision
Study Design
Total Participants: 76
Treatment Group(s): 1
Primary Treatment: Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum.
Phase:
Study Start date:
May 10, 2023
Estimated Completion Date:
March 16, 2024
Connect with a study center
Service de parasitologie et mycologie médicale
Lyon, 69004
FranceSite Not Available
Service de parasitologie et mycologie médicale
Lyon 2996944, 69004
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.